ATP-Citrat-Lyase
ATP Citrate Lyase inhibitors are compounds that target the enzyme ATP citrate lyase, which plays a key role in the biosynthesis of fatty acids and cholesterol by converting citrate to acetyl-CoA. In the context of neuroscience, these inhibitors are of interest due to their potential effects on lipid metabolism in the brain, which is crucial for maintaining neuronal function and integrity. Inhibiting ATP citrate lyase can have implications for neurodegenerative diseases, where lipid metabolism is often dysregulated. At CymitQuimica, we offer ATP citrate lyase inhibitors to support your research in brain metabolism, neurodegeneration, and therapeutic development.
17 Produkte aus dem Bereich "ATP-Citrat-Lyase" gefunden
Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
(-)-Hydroxycitric acid
CAS:(-)-Hydroxycitric acid from Garcinia cambogia rinds inhibits ATP citrate lyase, reducing fat synthesis and aiding weight loss.Formel:C6H8O8Reinheit:99.77% - 99.90%Farbe und Form:SolidMolekulargewicht:208.12(-)-Hydroxycitric acid lactone
CAS:(-)-Hydroxycitric acid lactone (Garcinia lactone) is an anti-obesity agent.(-)-Hydroxycitric acid lactone was a potent inhibitor of ATP citrate lyase, whichFormel:C6H6O7Reinheit:99.91%Farbe und Form:SolidMolekulargewicht:190.11Citric acid trilithium salt tetrahydrate
CAS:Citric acid trilithium salt tetrahydrate (Lithium citrate tribasic tetrahydrate) , the active component of Lithium, is a medicine used in the therapy ofFormel:C6H13Li3O11Reinheit:99.88%Farbe und Form:White Crystalline PowderMolekulargewicht:281.98Hydroxycitric acid tripotassium hydrate
CAS:Hydroxycitric acid tripotassium hydrate (Potassium citrate monohydrate) effectively inhibits HIF, has antioxidation, anti-inflammation, and anti-tumor effects.Formel:C6H7K3O8Reinheit:99.85%Farbe und Form:White Solid CrystallineMolekulargewicht:324.41Forrestiacids J
CAS:Forrestiacid J is an inhibitor of ATP-citrate lyase (ACL), exhibiting an IC50 value of 2.6 μM [1].Formel:C50H74O6Reinheit:98%Farbe und Form:SolidMolekulargewicht:771.12Forrestiacids K
CAS:Forrestiacid K, a terpenoid derived from Pseudotsuga forrestii, functions as an inhibitor of ATP-citrate lyase (ACL) [1].Formel:C50H74O6Reinheit:98%Farbe und Form:SolidMolekulargewicht:771.12ATP citrate lyase/ACLY Protein, Human, Recombinant (His)
ATP citrate lyase, also known as Acly or Acl, is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues.Reinheit:96%Farbe und Form:Lyophilized PowderMolekulargewicht:123 kDa (predicted); 110 kDa (reducing conditions)Ref: TM-TMPY-02483
5µg84,00€10µg119,00€20µg191,00€50µg376,00€100µg633,00€200µg1.075,00€500µg2.108,00€Anti-ATP citrate lyase/ACLY Antibody (9F685)
Anti-ATP citrate lyase/ACLY Antibody (9F685) is an antibody targeting ATP citrate lyase/ACLY. Anti-ATP citrate lyase/ACLY Antibody (9F685) can be used in ELISA, WB, IF, FCM.Farbe und Form:Odour LiquidSB 204990
CAS:SB 204990 is a lactone prodrug of SB-201076, a potent and specific ATP citrate lyase inhibitor.Cost-effective and quality-assured.Formel:C18H22Cl2O5Reinheit:96.32% - 99.6%Farbe und Form:SolidMolekulargewicht:389.27Bempedoic acid
CAS:Bempedoic acid (ETC1002) is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C.Formel:C19H36O5Reinheit:99.85% - 99.94%Farbe und Form:SolidMolekulargewicht:344.49Ref: TM-T3625
2mg34,00€5mg50,00€10mg70,00€25mg118,00€50mg207,00€100mg333,00€500mg797,00€1mL*10mM (DMSO)52,00€BMS-303141
CAS:BMS-303141 is a potent ATP-citrate lyase (ACL) inhibitor (IC50: 0.13 uM, human recombinant ACL).Formel:C19H15Cl2NO4SReinheit:98% - 99.47%Farbe und Form:SolidMolekulargewicht:424.3Ref: TM-T2337
1mg35,00€2mg47,00€5mg66,00€10mg87,00€25mg140,00€50mg268,00€100mg393,00€1mL*10mM (DMSO)69,00€NDI-091143
CAS:NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay),indirectly disrupting citrate bindingFormel:C20H14ClF2NO5SReinheit:97.03% - ≥95%Farbe und Form:SolidMolekulargewicht:453.842-Furoic acid
CAS:2-Furoic acid: oral cathepsin K inhibitor, potential for treating osteoporosis and antibacterial.Formel:C5H4O3Reinheit:99.53% - 99.65%Farbe und Form:SolidMolekulargewicht:112.08MEDICA16
CAS:MEDICA16: GPR40 agonist, GPR120 partial agonist, ATP-citrate lyase inhibitor, lowers TG, boosts insulin sensitivity in muscle.Formel:C20H38O4Reinheit:99.62% - 99.87%Farbe und Form:White SolidMolekulargewicht:342.51Ref: TM-T22967
5mg60,00€10mg92,00€25mg168,00€50mg289,00€100mg419,00€500mg874,00€1mL*10mM (DMSO)80,00€EVT0185
CAS:EVT0185 is an orally active ATP citrate lyase (ACLY) inhibitor. In the liver, it is converted by SLC27A2 into a CoA thioester, which interacts with the CoA binding site of ACLY. EVT0185-CoA inhibits ACLY activity with an IC50 of 2.5 μM. It mimics the immune and antitumor effects seen with ACLY gene deletion. Additionally, EVT0185 elevates levels of tumor-infiltrating B cells and the chemokine CXCL13. It is applicable in cancer research, including hepatocellular carcinoma (HCC).Formel:C22H34O4Farbe und Form:SolidMolekulargewicht:362.50ACLY Inhibitor 7
CAS:ACLY Inhibitor 7 is a potent, selective hACLY inhibitor (IC50<1 nM) for metabolic disease and oncology research.Formel:C21H14ClF2NO6SReinheit:99.74%Farbe und Form:SoildMolekulargewicht:481.85ACLY-IN-1
CAS:ACLY-IN-1 (compound 55) is a potent ACLY inhibitor with an IC50 of 8.3 nM, and it can be utilized in hyperlipidemia research.Formel:C20H12BrClF2N2O4SFarbe und Form:SolidMolekulargewicht:529.74
